Federal award
CEPHEID
W91YTZ22C0004
Contract
Obligated and Ceiling
- Obligated (net)
- $259,355.00
- Ceiling (potential value, not spending)
- $259,355.00
- Current value
- $259,355.00
- Gross positive obligations
- $487,668.75
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CEPHEID · W6HQTMWB9Q28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- DANAHER CORP · C81ZDK1LL4G7
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ22C0004
- Award type code
- D
- Actions
- 6 · Apr 26, 2022 to Jun 25, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History6
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 25, 2025 | FY2025 | P00005 | C | −$228,313.75 | — |
| Jun 28, 2024 | FY2024 | P00004 | C | $162,556.25 | — |
| Apr 26, 2024 | FY2024 | P00003 | G | $0.00 | — |
| Nov 22, 2023 | FY2024 | P00002 | M | $0.00 | — |
| Apr 26, 2023 | FY2023 | P00001 | G | $162,556.25 | — |
| Apr 26, 2022 | FY2022 | 0 | — | $162,556.25 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.